Helping Eliminate Marijuana Use Through Pediatric Practice
| Status: | Recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 13 - 25 |
| Updated: | 6/29/2018 |
| Start Date: | April 2016 |
| End Date: | March 2019 |
| Contact: | Kristen Kaseeska, MPH |
| Email: | kkaseeska@aap.org |
| Phone: | 847-434-4000 |
This study adapts the Public Health Service (PHS) 5As model for use with adolescent marijuana
users and pilot the intervention to test feasibility and acceptability in pediatric primary
care settings. The specific aims are as follows:
Aim 1: Develop a marijuana screening and brief counseling intervention for adolescents based
on the Public Health Service 5As model and previously developed adolescent smoking cessation
intervention.
Hypothesis 1: The 5As model can be adapted for use as a marijuana screening and counseling
intervention for adolescents.
Aim 2: Test the feasibility and acceptability of the 5As marijuana screening and brief
counseling intervention in pediatric primary care practice.
Hypothesis 2a: Pediatric clinicians will find the 5As intervention feasible and acceptable
for addressing marijuana use in routine clinical visits with adolescents and their families;
and
Hypothesis 2b: Adolescents will find the 5As intervention delivered by their clinicians to be
acceptable in the context of routine preventive services delivery.
users and pilot the intervention to test feasibility and acceptability in pediatric primary
care settings. The specific aims are as follows:
Aim 1: Develop a marijuana screening and brief counseling intervention for adolescents based
on the Public Health Service 5As model and previously developed adolescent smoking cessation
intervention.
Hypothesis 1: The 5As model can be adapted for use as a marijuana screening and counseling
intervention for adolescents.
Aim 2: Test the feasibility and acceptability of the 5As marijuana screening and brief
counseling intervention in pediatric primary care practice.
Hypothesis 2a: Pediatric clinicians will find the 5As intervention feasible and acceptable
for addressing marijuana use in routine clinical visits with adolescents and their families;
and
Hypothesis 2b: Adolescents will find the 5As intervention delivered by their clinicians to be
acceptable in the context of routine preventive services delivery.
The HEMPP study involves three phases: Researchers will (1) Develop a marijuana screening and
brief counseling intervention for adolescents, based on expert input, current literature, and
themes gathered from focus groups with adolescents and clinicians; (2) Pilot test the
acceptability of the 5As marijuana intervention in 2 pediatric primary care practices, where
researchers will test the intervention and determine acceptability via in-depth interviews
with clinicians, office staff, adolescents and parents; and (3) Pilot test the feasibility of
the 5As marijuana intervention in 8 practices (4 intervention/4 comparable control), wherein
each practice will enroll 100 adolescents and conduct baseline/exit interviews with all of
them. Twenty percent of adolescents/practice (including identified marijuana users) will
complete one follow-up interview 3-6 weeks after their practice visit. These interviews will
assess physician-delivery of the intervention and any change in use, attitude or behavioral
intentions toward marijuana since their clinical visit. Findings will inform the development
of a future large-scale trial of adolescent marijuana use, screening and cessation counseling
in pediatric primary care. The long-term goal is to improve clinical preventive services for
adolescent marijuana cessation. Conducting this work within the AAP PROS network will lead to
rapid dissemination of effective interventions.
brief counseling intervention for adolescents, based on expert input, current literature, and
themes gathered from focus groups with adolescents and clinicians; (2) Pilot test the
acceptability of the 5As marijuana intervention in 2 pediatric primary care practices, where
researchers will test the intervention and determine acceptability via in-depth interviews
with clinicians, office staff, adolescents and parents; and (3) Pilot test the feasibility of
the 5As marijuana intervention in 8 practices (4 intervention/4 comparable control), wherein
each practice will enroll 100 adolescents and conduct baseline/exit interviews with all of
them. Twenty percent of adolescents/practice (including identified marijuana users) will
complete one follow-up interview 3-6 weeks after their practice visit. These interviews will
assess physician-delivery of the intervention and any change in use, attitude or behavioral
intentions toward marijuana since their clinical visit. Findings will inform the development
of a future large-scale trial of adolescent marijuana use, screening and cessation counseling
in pediatric primary care. The long-term goal is to improve clinical preventive services for
adolescent marijuana cessation. Conducting this work within the AAP PROS network will lead to
rapid dissemination of effective interventions.
Inclusion Criteria:
- Adolescents presenting for regular well or sick visits at their pediatrician's office
- Must live in a home or apartment with access to a telephone and mailing address
- Must be cognitively able to consider the risks of marijuana use
- Must be able to speak English
- Must be able and willing to give informed consent (if 18 years of age or older) or
assent (if 14-17 years of age)
- In addition: parents/legal guardians of minors must be able and willing to give
informed consent
Exclusion Criteria:
We found this trial at
1
site
Elk Grove Village, Illinois 60007
Principal Investigator: V. Fan Tait, MD
Phone: 847-434-4000
Click here to add this to my saved trials
